Arrowhead Pharmaceuticals, Inc.

ExodusPoint Capital Management, LP ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

42,011

Value ($000)

2,789

Weight

0.0%

2019 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	2,789	0.0%	42,011	12/31/2025
2024 Q3	11/12/2024	1,722	0.0%	88,884	9/30/2024
2024 Q2	8/13/2024	1,846	0.0%	71,015	6/30/2024
2024 Q1	5/14/2024	1,963	0.0%	68,647	3/31/2024
2023 Q3	11/13/2023	863	0.0%	32,127	9/30/2023
2023 Q1	5/11/2023	352	0.0%	13,860	3/31/2023
2022 Q4	2/13/2023	1,353	0.0%	33,365	12/31/2022
2022 Q3	11/10/2022	2,290	0.0%	69,291	9/30/2022
2022 Q2	8/22/2022	1,662	0.0%	47,193	6/30/2022
2022 Q1	5/13/2022	303	0.0%	6,578	3/31/2022
2021 Q4	2/11/2022	3,883	0.0%	58,567	12/31/2021
2021 Q3	11/15/2021	1,010	0.0%	16,174	9/30/2021
2021 Q2	8/16/2021	939	0.0%	11,332	6/30/2021
2021 Q1	5/17/2021	452	0.0%	6,817	3/31/2021
2020 Q4	2/16/2021	829	0.0%	10,807	12/31/2020
2020 Q1	5/15/2020	408	0.0%	14,197	3/31/2020
2019 Q4	2/14/2020	1,377	0.0%	21,716	12/31/2019